论文信息 - TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status - 字舞流文

TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status

J. Mayerle | E. D. De Toni | U. Mahajan | S. Munker | Joscha Griger | Katharina Hammer | Liangtao Ye | N. Ben Khaled | F. Reiter | J. J. Montero | A. Alnatsha | S. Sirtl | I. Piseddu | Sebastian A. Widholz | J. Schneider | Enrico N. De De Toni | Ignazio Piseddu | Julia S. Schneider